UY28762A1 - NEW COMPOUNDS - Google Patents

NEW COMPOUNDS

Info

Publication number
UY28762A1
UY28762A1 UY28762A UY28762A UY28762A1 UY 28762 A1 UY28762 A1 UY 28762A1 UY 28762 A UY28762 A UY 28762A UY 28762 A UY28762 A UY 28762A UY 28762 A1 UY28762 A1 UY 28762A1
Authority
UY
Uruguay
Prior art keywords
new compounds
therapy
preparation
pharmaceutical compositions
compounds
Prior art date
Application number
UY28762A
Other languages
Spanish (es)
Inventor
Johansson Martin-Malmstrom
Jonas-Minidis
Alexander-Nilsson
Karolina-Wensbo
Andreas-Osterlund
Krister Andreas
Original Assignee
Astrazeneca Ab
Nps Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab, Nps Pharma Inc filed Critical Astrazeneca Ab
Publication of UY28762A1 publication Critical patent/UY28762A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Nuevos compuestos, un proceso para su preparación, su uso en terapia y composiciones farmacéuticas que comprenden dichos nuevos compuestos.New compounds, a process for their preparation, their use in therapy and pharmaceutical compositions comprising said new compounds.

UY28762A 2004-02-20 2005-02-18 NEW COMPOUNDS UY28762A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54590504P 2004-02-20 2004-02-20

Publications (1)

Publication Number Publication Date
UY28762A1 true UY28762A1 (en) 2005-08-31

Family

ID=34910738

Family Applications (1)

Application Number Title Priority Date Filing Date
UY28762A UY28762A1 (en) 2004-02-20 2005-02-18 NEW COMPOUNDS

Country Status (4)

Country Link
AR (1) AR047967A1 (en)
TW (1) TW200538180A (en)
UY (1) UY28762A1 (en)
WO (1) WO2005082884A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008012413A (en) * 2006-03-29 2008-10-07 Hoffmann La Roche Pyridine and pyrimidine derivatives as mglur2 antagonists.
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
AR080055A1 (en) 2010-02-01 2012-03-07 Novartis Ag DERIVATIVES OF PIRAZOLO- [5,1-B] -OXAZOL AS ANTAGONISTS OF THE RECEIVERS OF CRF -1
AR080056A1 (en) 2010-02-01 2012-03-07 Novartis Ag CICLOHEXIL-AMIDA DERIVATIVES AS ANTAGONISTS OF CRF RECEIVERS
EP2531490B1 (en) 2010-02-02 2014-10-15 Novartis AG Cyclohexyl amide derivatives as crf receptor antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3922735A1 (en) * 1989-07-11 1991-01-24 Hoechst Ag AMINOPYRIMIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THE AGENTS CONTAINING THEY AND THEIR USE AS FUNGICIDES
DE4029649A1 (en) * 1990-09-19 1992-03-26 Hoechst Ag New 2-pyridyl-pyrimidine derivs. - useful as fungicides
WO2001051045A2 (en) * 2000-01-13 2001-07-19 Tularik Inc. Modulators of the constitutive adrostane receptor (car): screening and treatment of hypercholesterolemia

Also Published As

Publication number Publication date
WO2005082884A3 (en) 2006-05-18
WO2005082884A2 (en) 2005-09-09
TW200538180A (en) 2005-12-01
AR047967A1 (en) 2006-03-15

Similar Documents

Publication Publication Date Title
UY30304A1 (en) MGLUR5 I MODULATORS
CR8717A (en) NEW COMPOUNDS
ES2524458T3 (en) DNase for the treatment of male subfertility
UY30308A1 (en) MGLUR5 V MODULATORS
UY30307A1 (en) MGLUR5 VI MODULATORS
UY27720A1 (en) MONOCYCLIC AROILPIRIDINONES,
UY30306A1 (en) MGLUR5 III MODULATORS
CL2008002319A1 (en) Compounds derived from pyrrolopyrimidine; pharmaceutical composition comprising said compounds; and its use to treat cancer.
AR106702A2 (en) USE OF ANTI-NGF ANTAGONIST ANTIBODY FOR THE PREPARATION OF A MEDICINAL PRODUCT
UY28342A1 (en) NEW COMPOUNDS
AR061348A1 (en) LAQUINIMOD STABLE PREPARATIONS
CL2008002381A1 (en) Immunostimulatory oligonucleotide; pharmaceutical composition comprising it; and its use to treat a disorder or condition in a subject, including cancer.
ECSP077999A (en) FORMULATIONS OF A MODIFIED LIBERATION BUPROPION SALT
BRPI0618904A2 (en) compound, pharmaceutical composition, and compound use
ES2422556T3 (en) Viral hepatitis treatment
CR8642A (en) COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE IN THE TREATMENT OF METABOLIC DISORDERS
BRPI0611956A2 (en) compound, use thereof, pharmaceutical composition, and process for preparing a compound
UY28348A1 (en) NEW COMPOUNDS
CR7828A (en) OXIALQUILAMIDS OF QUINOLINE, ISOQUINOLINA AND QUINAZOLINA AND ITS USE AS FUNGICIDES
CL2010000188A1 (en) A method for treating an infection in a subject comprising the administration of 9 - [(2,2-dimethyl-propylamino) -methyl] -minocycline or a salt thereof; pharmaceutical composition comprising said compound; and its use.
UY30309A1 (en) MGLUR5 II MODULATORS
CL2008001323A1 (en) Triazolyl aminopyridine derived compounds; pharmaceutical composition comprising said compounds; and its use to treat cancer.
NO20082376L (en) Pharmaceutical compositions
DOP2010000134A (en) SOME DERIVATIVES OF 2-PIRAZINONA AS INHIBITORS OF ELASTASA DE LOS NEUTROFILOS
CR9786A (en) BENCIMIDAZOL-THIOPHEN COMPOUNDS